Proactive London's Andrew Scott speaks to Braveheart Investment Group PLC's (LON:BRH) and Pharm2Farm Limited's (P2F) Gareth Cave following Braveheart's investment in the business.
P2F has developed a patented process to increase the bioavailability of trace minerals in plant feeds for both crops and flowers.
The process has now been developed for use in the growing of other commercial crops both in soil and hydroponically.
Price: 11.25 GBX
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Braveheart Investment Group named herein, including the promotion by the Company of Braveheart Investment Group in any Content on the Site, the...
FOR OUR FULL DISCLAIMER CLICK HERE
Trevor Brown, chief executive of Braveheart Investment Group PLC (LON:BRH), caught up with Proactive following the release of their interim results. The six months to the end of September saw the company declare a profit of £191,000 on revenue of £397,000. After a quick chat with...
